SEC Form 4 · accession 0001104659-16-144227
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Huda Y Zoghbi
Director
Period of report
Sep 9, 2016
Accepted (ET)
Sep 12, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $391.92 | Sep 9, 2016 | A | 15,353 | A | — | Sep 9, 2026 | Common Stock | 15,353 | 15,353 | D |
Explanation of responses
- F1The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.